Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Particle Therapy Market Size Changed, over the years?

In recent times, there has been significant growth in the size of the particle therapy market. Expected to expand from $1.23 billion in 2024 to $1.37 billion in 2025, the market will see a compound annual growth rate (CAGR) of 11.8%. The factors contributing to this growth in the historical period include clinical research and studies, a rise in cancer rates, government backing and funding, industry synergy, and enhancements in treatment planning.

How Much Will the Particle Therapy Market Be Worth in 2029?

Expectations are high for the particle therapy market as it is predicted to experience swift expansion in the coming years. By 2029, the market is anticipated to reach a value of $2.19 billion, with a Compound Annual Growth Rate (CAGR) of 12.4%. Several factors contribute to this projected growth within the forecast period, including an increase in healthcare spending, emerging applications extending beyond the scope of cancer, a growing elderly population, advances in healthcare infrastructure, and the integration of AI and data analytics. Some noteworthy trends in this forecast period encompass developments in particle accelerator technology, hypofractionation techniques, combined proton and carbon ion therapy, enhanced patient comfort, and biology-driven treatment models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Which is the Largest Company in the Particle Therapy Market?

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

What Are the Main Market Drivers in the Particle Therapy Industry?

The escalating incidence of cancer is predicted to fuel the expansion of the particle therapy market. Cancer is a diverse and intricate cluster of diseases marked by abnormal cell growth and multiplication in the body. Particle therapy is primarily used to treat cancer effectively and accurately with radiation, whereby positively charged particles (protons) are expedited to high velocities and then targeted on the tumor. For instance, as per the International Agency for Research on Cancer (IARC), a France-based, intergovernmental agency, in 2022, close to 20 million fresh cases of cancer were documented, resulting in nearly 10 million deaths due to the disease. Forecasts grounded on demographic trends indicate that the annual rate of fresh cancer cases could escalate to 35 million by 2050, signifying a 77% surge from the 2022 statistics. Therefore, the ascending incidence of cancer is propelling the expansion of the particle therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

How Is the Particle Therapy Market Segments Structured?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

What Strategic Trends Are Transforming the Particle Therapy Market?

There is an increasing trend towards the adoption of advanced particle therapy platforms in the particle therapy market. Significant players in this market are strategically innovating these platforms to maintain their foothold. For instance, in the month of July 2023, RaySearch Laboratories, a firm based in Sweden that specializes in medical technology, introduced RayStation 2023B. This novel system for oncology treatment planning brings numerous new progressions in particle therapy, such as the capacity for discrete proton arcs and potent optimization grounded on linear energy transfer (LET). The principle of LET optimization is to decrease possible side effects by lowering LET in organs at risk, while simultaneously guiding high LET particles towards tumors to enhance tumor control. Also, unique discrete proton arc optimization allows for a wider selection of beam angles, resulting in conformal dose distributions and diminishing exposure for organs at risk. The software simplifies the transition to standard pencil-beam scanning plans and integrates automatic field-in-field planning for photons, point-optimized planning for brachytherapy, and upgraded data loading speeds.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Global Regions Offer the Highest Growth in the Particle Therapy Market?

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12250

This Report Delivers Insight On:

1. How big is the particle therapy market, and how is it changing globally?

2. Who are the major companies in the particle therapy market, and how are they performing?

3. What are the key opportunities and risks in the particle therapy market right now?

4. Which products or customer segments are growing the most in the particle therapy market?

5. What factors are helping or slowing down the growth of the particle therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model